Reply to S. Sarosiek et al.

Buske, Christian; Dimopoulos, Meletios A; Morel, Pierre

Buske, Christian; Dimopoulos, Meletios A; Morel, Pierre.

Afiliação

Buske C; Christian Buske, MD, Christian Buske, MD, Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany; Meletios A. Dimopoulos, MD, PhD, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece; and Pierre Morel, MD, CHU Amiens Hôpital Sud, Amiens, France.
Dimopoulos MA; Christian Buske, MD, Christian Buske, MD, Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany; Meletios A. Dimopoulos, MD, PhD, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece; and Pierre Morel, MD, CHU Amiens Hôpital Sud, Amiens, France.
Morel P; Christian Buske, MD, Christian Buske, MD, Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany; Meletios A. Dimopoulos, MD, PhD, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece; and Pierre Morel, MD, CHU Amiens Hôpital Sud, Amiens, France.

J Clin Oncol ; 41(24): 4060-4061, 2023 Aug 20.

Article em En | MEDLINE | ID: mdl-37348018

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google